Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $15.40 Average Price Target from Analysts

Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Free Report) have been given a consensus recommendation of “Buy” by the seven research firms that are presently covering the firm, Marketbeat reports. Seven research analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued ratings on the […]

Leave a Reply

Your email address will not be published.

Previous post Brokerages Set Maple Leaf Foods Inc. (TSE:MFI) Target Price at C$30.07
Next post Brokerages Set ADTRAN Holdings, Inc. (NASDAQ:ADTN) PT at $10.50